Forget AI. This Biotech Stock’s Taking Off Right Now

Quick Read Nvidia (NVDA) and Eli Lilly (LLY, down 7% YTD, forward P/E under 30x) in $1B partnership. Eli Lilly deploys AI for drug discovery via Nvidia partnership and LillyPod supercomputer as biotech provides AI exposure at reasonable valuations. The analyst who called NVIDIA in 2010 just named his top 10 AI stocks. Get them here FREE. The market seems to be falling heavily out of love with the AI stocks, and for good reason: CapEx is rising at a staggering rate, especially among the Mag Seven A ...